Eli Lilly & Co. v. Teva Parenteral Medicines, Inc.

This document cites

• Federal Cases - Lilly v. Teva Parenteral Med. Inc.
• Federal Cases - Amgen Inc. v. F. Hoffmann-La Roche Ltd.
• Federal Cases - Application of Avery
• Federal Cases - Otsuka Pharm. Co. v. Sandoz, Inc., Appeal No. 2011-1126
• Federal Cases - Eurand, Inc. v. Mylan Pharms. Inc. (In re Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litig.), Appeal No. 2011-1399



See all quotations

• Federal Cases - Pfizer, Inc. v. Teva Pharmaceuticals Usa, Inc.
• Federal Cases - Sun Pharm. Indus. v. Eli Lilly And Co.
• Federal Cases - Geneva Pharmaceuticals v. Glaxosmithkline
• Federal Cases - General Foods Corp. v. Studiengesellschaft Kohle mbH
• US - Reference Stubs - Jurisdiction of the United States Court of Appeals for the Federal Circuit
• US - Reference Stubs - Conditions for patentability; non-obvious subject matter
• US - Reference Stubs - Claim for Relief Arising under 35 U.S.C. Section 271(e)(2) or 42 U.S.C. Section 262
• US - Reference Stubs - Pediatric studies of drugs